Somaxon
Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Somaxon Information
Somaxon was acquired by
Pernix Therapeutics.
The acquisition happend on 2013-03-06.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 10935 Vista Sorrento Pkwy
City: San Diego
State: CA
Zip: 92130
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$6M
Raised Total:$94M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon currently is promoting Silenor®, the first and only nonscheduled prescription medication approved for the treatment of sleep maintenance insomnia. Silenor is now available for prescription in the United States.
Contact Phone:
+18588766500
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
